Schizoaffective Disorder

  • Medical Author:
    Roxanne Dryden-Edwards, MD

    Dr. Roxanne Dryden-Edwards is an adult, child, and adolescent psychiatrist. She is a former Chair of the Committee on Developmental Disabilities for the American Psychiatric Association, Assistant Professor of Psychiatry at Johns Hopkins Hospital in Baltimore, Maryland, and Medical Director of the National Center for Children and Families in Bethesda, Maryland.

  • Medical Editor: Melissa Conrad Stöppler, MD
    Melissa Conrad Stöppler, MD

    Melissa Conrad Stöppler, MD

    Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.

Quick GuideSchizophrenia: Symptoms, Types, Causes, Treatment

Schizophrenia: Symptoms, Types, Causes, Treatment

Is it possible to prevent schizoaffective disorder?

Once schizoaffective disorder has occurred, prevention of future episodes is best achieved when the person suffering from the illness receives consistent treatment, including medication and psychosocial treatment of their symptoms.

Are there support groups for schizoaffective disorder?

National Alliance on Mental Illness

Where can people find more information on schizoaffective disorder?

American Psychiatric Association

American Psychological Association

National Alliance for the Mentally Ill (NAMI)

National Institutes of Health

Medically reviewed by Marina Katz, MD; American Board of Psychiatry & Neurology


Abrams, D.J., D.C. Rojas, and D.B. Arciniegas. "Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature." Neuropsychiatric Disorders Treatment 4.6 Dec. 2008: 1089-1109.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association 2013, Arlington, Virginia.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. American Psychiatric Association 2000, Washington, D.C.

Baker, A.L., et al. "Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review." Journal of Clinical Psychiatry 71.3 Mar. 2010: 247-254.

Daumit, G.L., R.W. Goldberg, C. Anthony, et al. "Physical activity patterns in adults with severe mental illness." Journal of Nervous and Mental Disease 193.10 Oct. 2005: 641-646.

Harkavy-Friedman, J.M., E.A. Nelson, D.F. Venarde, and J.J. Mann. "Suicidal behaviour in schizophrenia and schizoaffective disorder: examining the role of depression." Suicide Life-Threat 34 (2004): 66-76.

Heckers, S. "Is schizoaffective disorder a useful diagnosis?" Current Psychiatric Reports (2009): 332-337.

Laursen, T.M., R. Labouriau, R.W. Licht, et al. "Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study FREE." Archives of General Psychiatry 62.8 (2005): 841-848.

Lysaker, P.H., N.L. Beattie, A.M. Strasburger, et al. "Reported history of child sexual abuse in schizophrenia: Associations with heightened symptom levels and poorer participation over four months in vocational rehabilitation." Journal of Nervous and Mental Disease 193.13 Dec. 2005: 790-795.

Mazza, M., M. Di Nicola, G. Martinotti, et al. "Oxcarbazepine in bipolar disorder: a critical review of the literature." Expert Opinion on Pharmacotherapy 8.5 (2007): 649-656.

Robinson, D.G., M.G. Woerner, M. McMeniman, et al. "Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder." The American Journal of Psychiatry 161.3 Mar. 2004: 473-479.

Schottle, D., B.G. Schimmelmann, P. Conus, et al. "Differentiating schizoaffective and bipolar I disorder in first-episode psychotic mania." Schizophrenia Research 140.1-3 Sept. 2012: 31-36.

Smeraldi, E., R. Cavallaro, V. Folnegovic-Smalc, et al. "Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)." Therapeutic Advances in Psychopharmacology Mar. 2013.

Stauder, A.D. "Group motivational interviewing as a psychotherapeutic intervention for dual diagnosis patients living with a psychotic disorder: critique of the literature." Graduate Journal of Counseling Psychology 3.1 (2012).

Varese, F., F. Smeets, M. Drukker, R. Lieverse, et al. "Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective and Cross-sectional Cohort Studies." Schizophrenia Bulletin 2012.

Vieta, E. "Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation." Journal of Clinical Psychiatry 71.2 (2010): 14-19.

Medically Reviewed by a Doctor on 3/2/2016

Subscribe to MedicineNet's Newsletters

Get the latest health and medical information delivered direct to your inbox!

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors